BABA vs CPS

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

CPS exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a negative Price-to-Book ratio of -6.80, indicating negative shareholders' equity. While the stock has seen a 1-year price surge and analysts maintain a 'buy' rating with a target of $51.88, the fundamental data shows collapsing earnings growth (-91.9%) and stagnant revenue. The disconnect between the technical price action and the deterministic health scores suggests a high-risk speculative play rather than a value investment. Liquidity is tight with a quick ratio of 0.97, barely covering short-term obligations.